Heterologous prime-boost vaccination with MF59-adjuvanted H5 vaccines promotes antibody affinity maturation towards the hemagglutinin HA1 domain and broad H5N1 cross-clade neutralization - Wikidata - awgldk - TriplyDB

Heterologous prime-boost vaccination with MF59-adjuvanted H5 vaccines promotes antibody affinity maturation towards the hemagglutinin HA1 domain and broad H5N1 cross-clade neutralization

Heterologous prime-boost vaccination with MF59-adjuvanted H5 vaccines promotes antibody affinity maturation towards the hemagglutinin HA1 domain and broad H5N1 cross-clade neutralization

http://www.wikidata.org/entity/Q30361644

about

Can follicular helper T cells be targeted to improve vaccine efficacy?B Cells and Functional Antibody Responses to Combat Influenza Improving pandemic H5N1 influenza vaccines by combining different vaccine platforms.Effect of influenza A(H5N1) vaccine prepandemic priming on CD4+ T-cell responses.A cationic liposome-DNA complexes adjuvant (JVRS-100) enhances the immunogenicity and cross-protective efficacy of pre-pandemic influenza A (H5N1) vaccine in ferrets.Antibody Persistence and Booster Responses to Split-Virion H5N1 Avian Influenza Vaccine in Young and Elderly Adults.A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines.Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets.Heterologous prime-boost vaccination with H3N2 influenza viruses of swine favors cross-clade antibody responses and protection.AS03- and MF59-Adjuvanted Influenza Vaccines in Children.Broad cross-reactive IgG responses elicited by adjuvanted vaccination with recombinant influenza hemagglutinin (rHA) in ferrets and mice.CD4 T cells in protection from influenza virus: Viral antigen specificity and functional potential

P2860

Q26753848-BEBAE570-BFF0-4CA3-8C0C-DCE43E9E2285 Q26801639-BDADF762-1F01-4BC6-8A3F-E305E572F3F2 Q30362811-FAAC6ADD-612E-46CA-8ABB-A6EE0D5CACE4 Q30368474-EFB8598C-3022-4E87-967D-328A5A20CBA1 Q30385570-BAD68215-4333-4582-B421-1F10C71F687E Q30394896-089E83A1-5F16-4903-B5B6-C43C5623A53E Q30401247-CFE2F05D-6BE6-4269-8C2B-6BB9A00E0561 Q30402500-7165B4D5-F370-4F23-A18F-4D9C570E57F8 Q46060826-AA43E66A-363D-4E4C-9E31-920ED830A3CA Q47658890-FDE9F6DA-FDF4-46D0-A903-74CF72E64A7E Q52594170-6D642F9A-57D6-44B3-B854-EB72CA82C7B0 Q57094380-EA69066A-6799-4191-B6C8-A1928B641116

P2860

Heterologous prime-boost vaccination with MF59-adjuvanted H5 vaccines promotes antibody affinity maturation towards the hemagglutinin HA1 domain and broad H5N1 cross-clade neutralization

http://www.wikidata.org/entity/Q30361644

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Heterologous prime-boost vacci ...... 5N1 cross-clade neutralization

@ast

Heterologous prime-boost vacci ...... 5N1 cross-clade neutralization

@en

type

label

Heterologous prime-boost vacci ...... 5N1 cross-clade neutralization

@ast

Heterologous prime-boost vacci ...... 5N1 cross-clade neutralization

@en

prefLabel

Heterologous prime-boost vacci ...... 5N1 cross-clade neutralization

@ast

Heterologous prime-boost vacci ...... 5N1 cross-clade neutralization

@en

P1433

Q30361644-C7235600-971A-48E7-BD1D-5B32CB28F4A9

P1476

Q30361644-491F9D63-A24B-4265-8CC4-AD126E6C1536

P2093

Q30361644-1767C6C0-04B1-46D9-8218-0BBB790AA4D2

Q30361644-43C80F96-4E03-44CE-9B89-F3220A04F56D

Q30361644-5A3E8F97-931D-4A25-9DDF-8B4DA39D2808

Q30361644-63298440-25D6-4EAA-BE3E-0132B86091D1

Q30361644-AFEB21A5-67B5-4FDA-BD9F-18BB690DC146

Q30361644-B2949BD8-9065-473F-878D-E2DF0AD714CC

Q30361644-D76DE2C4-A4B9-4401-9E1A-E4E75638A370

P2860

Q30361644-08C79F97-0310-4F3D-B58B-FDB91F256B92

Q30361644-13664DDE-11AB-47F2-8792-64F49B716B51

Q30361644-16AC3A7B-6162-4DDD-A02C-0CFA22370399

Q30361644-1B588883-174E-4C4C-942F-B86E9F0A295F

Q30361644-283E7A3F-9A55-41CA-8FEA-DA838F574D0C

Q30361644-3B46C773-1E5A-4F62-BBE3-681FCF2F6F63

Q30361644-44A8CFFD-DA45-4AD5-A07F-A964C91602D5

Q30361644-4854E6EC-D994-4F0B-BE5F-0DECF6DE8C37

Q30361644-4A67492A-1469-4E45-AE2E-28894CC1347F

Q30361644-4A91812E-50CF-48BB-8C81-8E6B6B4E1EDE

P304

Q30361644-7740C5E2-CDA8-475E-97A7-632623443BAE

P31

Q30361644-8515B1E2-3DD1-4342-B2B1-899ED8E80E46

P356

Q30361644-8B8CB4BB-E6FC-4081-9071-AF10F4E7400C

P407

Q30361644-AC0BDD41-4ED3-47EE-81DF-57FC3622A0C3

P433

Q30361644-6B195387-F726-4DDC-8687-430966E91214

P478

Q30361644-6A020AA0-7BDB-4889-960A-C3BAD75F0FC7

P577

Q30361644-4EE148B6-D37F-441A-A7F9-2F0480D7C64E

P5875

Q30361644-5A479812-BF42-41D8-AFCF-0E2539F10079

P698

Q30361644-B2FAEFCD-A6ED-448B-BB5C-3E12189B885B

P921

Q30361644-286C49A4-35CD-44B9-8B83-4DDFDB89B7E1

P932

Q30361644-F09D84C6-0A76-4287-9C97-C717FFEFBBB9

P356

JOURNAL.PONE.0095496

P1433

P1476

Heterologous prime-boost vacci ...... 5N1 cross-clade neutralization

@en

P2093

Elizabeth M Coyle

http://www.w3.org/2001/XMLSchema#string

Flora Castellino

http://www.w3.org/2001/XMLSchema#string

Giuseppe Del Giudice

http://www.w3.org/2001/XMLSchema#string

Hana Golding

http://www.w3.org/2001/XMLSchema#string

Karl Nicholson

http://www.w3.org/2001/XMLSchema#string

Milena Dimitrova

http://www.w3.org/2001/XMLSchema#string

Surender Khurana

http://www.w3.org/2001/XMLSchema#string

P2860

Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo

Antibody recognition of a highly conserved influenza virus epitope

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults

Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets

Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine.

Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.

Influenza vaccine immunology.

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection.

MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines.

P304

e95496

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0095496

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261801124

http://www.w3.org/2001/XMLSchema#string

P698

24755693

http://www.w3.org/2001/XMLSchema#string

P921

P932

3995799

http://www.w3.org/2001/XMLSchema#string